Chemours Co (NYSE:CC) has earned an average rating of “Hold” from the fifteen analysts that are covering the stock, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $23.15.

Several research analysts have recently commented on CC shares. Cfra upgraded Chemours from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. ValuEngine upgraded Chemours from a “sell” rating to a “hold” rating in a research report on Friday, January 3rd. JPMorgan Chase & Co. lowered their price target on Chemours from $21.00 to $19.00 and set a “neutral” rating for the company in a research report on Friday, December 20th. UBS Group lowered their price target on Chemours from $19.00 to $14.50 and set a “neutral” rating for the company in a research report on Wednesday, October 2nd. Finally, SunTrust Banks raised their price target on Chemours to $20.00 and gave the stock a “hold” rating in a research report on Wednesday, November 6th.

Large investors have recently added to or reduced their stakes in the stock. Point72 Hong Kong Ltd purchased a new position in Chemours in the second quarter valued at $29,000. Cerebellum GP LLC raised its position in shares of Chemours by 107.8% during the 3rd quarter. Cerebellum GP LLC now owns 1,490 shares of the specialty chemicals company’s stock worth $75,000 after purchasing an additional 773 shares during the last quarter. FNY Investment Advisers LLC raised its position in shares of Chemours by 650.0% during the 4th quarter. FNY Investment Advisers LLC now owns 2,250 shares of the specialty chemicals company’s stock worth $40,000 after purchasing an additional 1,950 shares during the last quarter. Parallel Advisors LLC raised its position in shares of Chemours by 479.4% during the 3rd quarter. Parallel Advisors LLC now owns 2,312 shares of the specialty chemicals company’s stock worth $35,000 after purchasing an additional 1,913 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its position in shares of Chemours by 423.4% during the 3rd quarter. Quadrant Capital Group LLC now owns 2,727 shares of the specialty chemicals company’s stock worth $36,000 after purchasing an additional 2,206 shares during the last quarter. Hedge funds and other institutional investors own 76.22% of the company’s stock.

CC opened at $18.11 on Thursday. Chemours has a 52 week low of $11.71 and a 52 week high of $41.60. The business has a fifty day simple moving average of $17.09 and a 200-day simple moving average of $16.60. The firm has a market cap of $2.98 billion, a P/E ratio of 3.19, a P/E/G ratio of 0.38 and a beta of 2.55. The company has a quick ratio of 0.98, a current ratio of 1.72 and a debt-to-equity ratio of 5.05.

Chemours (NYSE:CC) last released its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.56 by $0.03. Chemours had a return on equity of 58.38% and a net margin of 7.24%. The business had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same period last year, the business posted $1.49 earnings per share. The company’s quarterly revenue was down 14.6% on a year-over-year basis. Sell-side analysts expect that Chemours will post 2.37 earnings per share for the current year.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

Further Reading: Gap Down Stocks

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.